cowtown jay
17 hours ago
I was wondering when John Hohneker would show up again.
ArriVent Appoints John Hohneker, M.D., to its Board of Directors
May 16, 2024
https://ir.arrivent.com/news-releases/news-release-details/arrivent-appoints-john-hohneker-md-its-board-directors
Cheryl Buxton appears to serve as an Independent Director for Wallmine investment advisors.
https://wallmine.com/otc/hgen/officer/2051278/cheryl-buxton
And we know Kevin Xie's Gracell is now a subsidiary of AstraZeneca, and likely a lenzilumab licensee. I always thought there was an opportunity for us to improve the safety and efficacy of AZ's covid vaccine, in addition to their acquired CAR-T.
https://www.astrazeneca.com/media-centre/press-releases/2024/acquisition-of-gracell-completed.html
US-JUSTICE
1 day ago
The King of France owed huge debt to the knights of templars to fund wars and he could not pay so what he did, he killed the creditors by making false accusations of devil worshipping by the knight templars who are not the free masons.
Now with debts that are unreasonable and unjustified, the debtor can just kill the credistors as what the Germans did in war world 2. it was given unfair fines in the versailles treaty and debt carried interest so by 1930 due to high inflation the debt exploded, and no way Germany can repay the war debts or be 'enslaved' so it declared war on France and England. all because the debt given to Germany was excessive, unfair and unreasonable, the debt would have enslave the country if it was not written off after world war 2.
cowtown jay
1 day ago
The Authorized Shares is 225M, and 119,080,135 of those shares are issued and Outstanding.
At one time, I think management was contemplating a 5:1 forward split. We may still see something like that. For example, maybe Taran will offer 5 shares of their stock, for every one share of HGEN stock, and end up with an OS of 595,400,675 shares. That OS was reported for us, at one time.
Any news will result in more than enough to pay off our Unsecured Creditors, and have this bankruptcy discharged. Remember, after TLD, I was able to sell shares at an average price of ~$28 (x 119,080,135 = a Market Cap of $3.3B, even without the spike of a recall of the loaned shares, or news regarding CMML).
We're dealing with the US government owning a sizable chunk of Moderna, and the ECB and German government heavily invested in Pfizer, plus these governments are providing the majority of the Regulatory Agencies' operating expenses, with government scientists also earning royalties from these companies.
So I agree that the best move is to look to Australia for the approval of lenz to treat CMML.
Management has more ice water in their veins than we do. I think it represents nothing less than stone cold resolve, and means that we will succeed.
US-JUSTICE
1 day ago
And for the $5 million dollar management insurance which was bough in 2022 and company filed a claim in 2023,, what insurance would not raise red flag that its insurance fraud. with some insurance companyagainst management lawsuits or management misconduct. it's just for legal fees or any fines the company has to pay for 'employee misconduct' the employees if they commit crimes are still personally liable for their 'crimes' if criminally responsible. and the money is paid to the company not the employee or any creditor claims.
management think they are buying insurance for murder or robbery. there is no insurance for robbery, if you found guilty of robbery or murder, the employee goes to jail. insurance is just to cover the cost of legal fees and fines in civil cases not criminal charges.
who sell that kind of insurance.
it's like the music companies buying insurance for their singers if the singer on contract dies, the music company gets paid $10 million insurance payment. the music company could have killed the singer and say it was suicide type of insurance fraud. like in korea, how can that many actors and singers just commit suicide. someone bought life 'business' insurance for them.
cowtown jay
1 day ago
"Myelodysplastic syndrome (MDS) is a group of cancers that affect the bone marrow and blood. In MDS, immature blood cells in the bone marrow don't develop normally and instead die or become unhealthy. This can lead to a buildup of defective cells over time, which can cause problems like anemia, leukopenia, and thrombocytopenia."
https://www.mayoclinic.org/diseases-conditions/myelodysplastic-syndrome/symptoms-causes/syc-20366977#:~:text=In%20a%20healthy%20person%2C%20bone,%2Dclotting%20platelets%20(thrombocytopenia).
I will not be surprised if lenzilumab is being used in the treatment of MDS in Mayo Clinic's Investigator Initiated Trial (IIT). And I think our CMO, Dr. Michael W Schuster, could be aiding Mayo in their IIT. This is his area of expertise.
https://doctors.stonybrookmedicine.edu/provider/Michael+W+Schuster/2250408
cowtown jay
2 days ago
Thank you very much for providing that information, which did include Board of Director fees for Cheryl and all of the other Board members. But that is not the document I was looking for. I'll post it, when I see it again.
I don't think there is necessarily anything adversarial involved. I did, initially. But Kevin Xie probably coordinated the integration of lenz into the highly enhanced CAR-T platform used by Gracell, and I suspect they are paying license fees to us. I think the BOD resignations were scripted, and designed to disqualify us from NASDAQ. It was in the KBIO playbook.
The recall of my car, which has now been at the dealership for about a month, is going to cost me thousands to repair, and I need good financial news, not more of the same surprises I've been dealing with.
cowtown jay
2 days ago
"...some non existent illegal hidden share scheme."
If a distribution is allowed to existing equity account holders, the identity of those holders will be determined "...(as reflected by DTC and/or the Debtorโs official register of holders of common stock)."
see Allowance, pg 52/85
https://document.epiq11.com/document/getdocumentsbydocket/?docketId=1089767&projectCode=HUM&docketNumber=309&source=DM
I was right to note the significance of the reported float of 192% of our Outstanding Shares, and to assume that total came from the Transfer Agent.
Even the latest version of our antagonist recognizes that there are more shares in our market, than issued by the company, if he thinks we have someone holding 110M shares, and there are another 36M shares out there somewhere.
cowtown jay
2 days ago
I mention the following should it be worth doing so.
"To me, part of the reason for investing here has always been a stock play, such (as) they executed previously DBA Kalobios."
I've never considered the PPS as reflective of the value of the stock. The value I have always considered was based on the projected value, when management recalls their loaned shares. It is for this reason that I have maintained open sell orders priced at $200.
Therefore, it is not mere ownership of shares that constitute my Equity Claim. My equity claim is based on a stated float that was reported at 192% of the Outstanding Shares, and knowing that excess shares in the market will have to be bought-in, in the event of a recall of the loaned shares, or a merger.
see pgs 4-5/26
"A. Equity Claims
13. The Debtor objects to the Equity Claims identified on Exhibit A to the Proposed Order because such claims relate solely to the mere ownership of equity security interests in the Debtor (as opposed to a claim arising from such ownership). Therefore, the Equity Claims do
not constitute a โclaimโ within the meaning of section 101(5) of the Bankruptcy Code. "
https://document.epiq11.com/document/getdocumentsbydocket/?docketId=1079544&projectCode=HUM&docketNumber=254&source=DM
Having said the above, I recognize that no recall of the loaned shares has yet been issued, nor has a merger been announced. However, management has to maintain control of a possible distribution to equity holders, even if motion is made to convert the bankruptcy to CH7.
US-JUSTICE
3 days ago
that is how bankruptcy chapter 11 works. after all the assets are sold any if any money is paid to the creditors, in this case, there is no money to pay anyone. less than 1 million so that 40 million 'fake liability' against the assets get nothing as all the money is in some 'trust' fund. funds in at trust are impossible to get out without the approval of the trustee. trust fund have a charter saying how the money is paid out too. but that is if the trustee can be trusted. lots of trust funds, the trustee bills the trust fund like percentage of value of assets or annual 'management fee' and sometimes the management fee is so high after a few years, there is no money in the fund. there is less than $500,000 in the fund if the trustee is billing the fund $200,000/year, plus trust fund expenses all the money is gone in a year.
cowtown jay
3 days ago
I don't know what you're talking about, but neither do you. And you're certainly not in position to determine the validity of the claims against the company. The chief invalid claim is that the ACTIV-5 trial did not corroborate the results of the LIVE-AIR trial. The truth is, the ACTIV-5 trial was designed to fail, and failure to meet the endpoint of that trial of late-stage patients, had nothing to do with the successful treatment of the early-stage LIVE-AIR patients. And the class action tort lawyers who brought suit against the company were totally derelict in their duty.
Your reply failed to address the issue I presented in my post. What does that information mean to you?
My concern was in regards to the Liquidation Trustee having sole discretion to declare a distribution to existing equity holders. It seems to me that Humanigen management shares that concern, and their objection still appears to be on tomorrow's docket. I think they intend to safeguard claims of equity interest accounts, not only on shareholders' behalf, but on Humanigen's behalf, as well, since I think they control ~90% of our Outstanding Shares.
https://document.epiq11.com/document/getdocumentbycode?docId=4343828&projectCode=HUM&source=DM